ZEPU AI9 lower-limb exoskeleton gait training for walking difficulties
Official title: Feasibility, Safety and Efficacy of ZEPU AI9 Lower Limb Exoskeleton Rehabilitation Robot in Patients With Lower Limb Motor Dysfunction
Run by Bangladesh Medical University · NCT07750808 · Data updated 2026-11-12
This study tests whether the ZEPU AI9 exoskeleton can be safely and effectively added to standard rehabilitation to improve walking for adults with stroke, incomplete spinal cord injury, or gait problems after orthopedic surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | Bangladesh Medical University Academic / other |
| Locations | 1 site (Dhaka) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07750808 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–60 with recent motor impairment from stroke, incomplete spinal cord injury, or orthopedic surgery and who meet device and medical safety criteria.
✕Probably not a fit
Patients with complete spinal cord injury or contraindications to exoskeleton use may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial compares exoskeleton-assisted gait training plus standard rehabilitation to standard rehabilitation alone in adults with walking impairments due to stroke, incomplete spinal cord injury, or orthopedic surgery. It aims to assess safety (e.g., device-related adverse events), tolerability, and functional outcomes such as walking distance, speed, balance, and leg strength. The ZEPU-AI9 is a dual-leg, motorized exoskeleton that guides hip and knee movements and supports safe over-ground and in-clinic training, with built-in safety features and a supervised harness. Participants will be randomized to the exoskeleton group or usual care, and the program will be tailored to each person's size and abilities. The study addresses implementation in a low-to-middle-income country setting by evaluating practicality within Bangladeshi rehabilitation services.
Why it matters
Potential benefit: If successful, patients could see improved walking ability and more efficient access to high-quality gait training.
How similar studies have gone: Robotic-assisted gait training has shown benefits in similar populations, though this specific device and local implementation are relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 and ≤ 60 years. * Lower-limb motor dysfunction from one of the following: (a) stroke (onset 2-24 months), (b) incomplete spinal-cord injury (neurological level T12 and below, ASIA C or D), (c) orthopedic surgery (e.g., knee/hip replacement) with persistent gait impairment \> 3months post-surgery. * Able to provide informed consent and understand instructions. * Weight ≤ 100 kg (as per device spec) and height within device adjustable range (manufacturer spec). * Medically stable and cleared by physician for exoskeleton use (no active infection, uncontrolled cardiac/respiratory disease, severe osteoporosis, uncontrolled epilepsy, untreated DVT) with necessary investigations. Exclusion Criteria: * Complete spinal cord injury with inability to bear any weight. * Severe cognitive impairment (e.g., MMSE \< 24) preventing safe participation. * Severe spasticity (Modified Ashworth Scale \> 3) in lower limbs. * Unstable fractures, severe hip/knee contractures (\> 30° fixed flexion), severe osteoarthritis requiring imminent surgery. * Uncontrolled cardiac arrhythmia, pacemaker incompatibility, or implanted electronic device incompatible with robot sensors. * Pregnancy.
Where it's running
-
Bangladesh Medical University
Dhaka, Bangladesh Recruiting
Study contacts
- Principal investigator: Md. Abdus Shakoor, Ph.D. — Bangladesh Medical University
- Study coordinator: Md. Abdus Shakoor, Ph.D.
- Email: shakoorma@bmu.ac.bd
- Phone: +8801819410080
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Trans-spinal magnetic stimulation for improving mobility in chronic stroke patients
This study is testing if a new type of magnetic treatment can help improve walking and movement in adults who have had a stroke for a long time.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.